Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.4 HKD | -2.79% | +4.67% | -16.15% |
04-26 | RemeGen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-04 | Remegen Gets US FDA Fast Track Designation for Primary Sjögren's Syndrome Medication | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.15% | 3.53B | |
+3.16% | 108B | |
+10.81% | 104B | |
+1.28% | 22.33B | |
-12.86% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.99% | 17.64B | |
+4.08% | 14.05B | |
+35.40% | 12.51B |
- Stock Market
- Equities
- 9995 Stock
- News RemeGen Co., Ltd.
- Remegen Gets US FDA Fast Track Designation for Primary Sjögren's Syndrome Medication